Yousif Capital Management LLC Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Yousif Capital Management LLC reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,566 shares of the medical equipment provider’s stock after selling 1,364 shares during the period. Yousif Capital Management LLC’s holdings in Intuitive Surgical were worth $18,746,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in ISRG. International Assets Investment Management LLC raised its holdings in Intuitive Surgical by 14.9% during the third quarter. International Assets Investment Management LLC now owns 2,116 shares of the medical equipment provider’s stock worth $617,000 after purchasing an additional 275 shares in the last quarter. Arkadios Wealth Advisors raised its holdings in Intuitive Surgical by 30.2% during the third quarter. Arkadios Wealth Advisors now owns 1,318 shares of the medical equipment provider’s stock worth $385,000 after purchasing an additional 306 shares in the last quarter. Global Retirement Partners LLC raised its holdings in Intuitive Surgical by 9.9% during the third quarter. Global Retirement Partners LLC now owns 1,852 shares of the medical equipment provider’s stock worth $538,000 after purchasing an additional 167 shares in the last quarter. Flagship Harbor Advisors LLC grew its position in Intuitive Surgical by 4.2% during the third quarter. Flagship Harbor Advisors LLC now owns 2,783 shares of the medical equipment provider’s stock worth $813,000 after buying an additional 113 shares during the period. Finally, Fifth Third Wealth Advisors LLC grew its position in Intuitive Surgical by 74.0% during the third quarter. Fifth Third Wealth Advisors LLC now owns 1,018 shares of the medical equipment provider’s stock worth $298,000 after buying an additional 433 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of the stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now owns 189 shares of the company’s stock, valued at $69,958.35. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, VP Fredrik Widman sold 5,041 shares of the stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the transaction, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 4,318 shares of the stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now directly owns 189 shares in the company, valued at approximately $69,958.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 248,418 shares of company stock worth $95,927,097. 0.80% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $8.15 during mid-day trading on Tuesday, reaching $377.08. 1,836,588 shares of the stock were exchanged, compared to its average volume of 1,677,112. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $403.76. The business’s fifty day simple moving average is $386.54 and its 200 day simple moving average is $344.98. The stock has a market capitalization of $133.66 billion, a PE ratio of 68.07, a PEG ratio of 5.69 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the business earned $1.00 earnings per share. Intuitive Surgical’s revenue was up 11.5% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Truist Financial upped their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Raymond James upped their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research report on Thursday, January 25th. Citigroup upped their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Finally, StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.